NeoVanc
Treatment of late onset bacterial sepsis caused by vancomycin susceptible bacteria in neonates and infants aged under three months
ARC
The effects of augmented renal clearance on the pharmacokinetic/pharmacodynamic profile of selected ß-lactam antibiotics in children and young adults with cancer
SPIROPK
Pharmacokinetics of spironolactone in children up to 2 years of age
Ampitsilliin, penitsilliin, gentamütsiin, vankomütsiin
Pharmacokinetics of antimicrobials in neonates